Inhibition of VEGF-R2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function

被引：0

作者：

Villalta, S. ^{[1
]}

Lang, Jiena ^{[1
]}

Kubeck, Samantha ^{[1
]}

Kabre, Beniwende ^{[1
]}

Szot, Gregory ^{[1
]}

Calderon, Boris ^{[2
]}

Brekken, Rolf ^{[3
]}

Pullen, Nick ^{[5
]}

Arch, Robert ^{[4
]}

Bluestone, Jeffery ^{[1
]}

机构：

[1] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA

[2] Washington Univ, Dept Pathol & Immunol, Dallas, MO USA

[3] UT Southwestern Med Ctr, Div Surg Oncol, Dallas, TX USA

[4] Pfizer Inc, Pfizer Global Res & Dev, Chesterfield, MO USA

[5] Pfizer Inc, Pfizer Global Res & Dev, Cambridge, MA USA

来源：

JOURNAL OF IMMUNOLOGY | 2013年 / 190卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P5181

引用

页数：1

共 50 条

[1] Inhibition of VEGFR-2 Reverses Type 1 Diabetes in NOD Mice by Abrogating Insulitis and Restoring Islet Function
Villalta, S. Armando
Lang, Jiena
Kubeck, Samantha
Kabre, Beniwende
Szot, Gregory L.
Calderon, Boris
Wasserfall, Clive
Atkinson, Mark A.
Brekken, Rolf A.
Pullen, Nick
Arch, Robert H.
Bluestone, Jeffrey A.
DIABETES, 2013, 62 (08) : 2870 - 2878
[2] The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice
Huusko, Jenni
Merentie, Mari
Dijkstra, Marike H.
Ryhanen, Minttu-Maria
Karvinen, Henna
Rissanen, Tuomas T.
Vanwildemeersch, Maarten
Hedman, Marja
Lipponen, Jukka
Heinonen, Suvi E.
Eriksson, Ulf
Shibuya, Masabumi
Yla-Herttuala, Seppo
CARDIOVASCULAR RESEARCH, 2010, 86 (01) : 122 - 130
[3] Toceranib phosphate (Palladia) reverses type 1 diabetes by preserving islet function in mice
Kishi, Kazuhisa
Yonezawa, Tomohiro
Kaji, Noriyuki
Goto, Momo
Nonoshita, Yuma
Iio, Aki
Tsuru, Yoshiharu
Hori, Masatoshi
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2023, 85 (07): : 781 - 789
[4] Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes
Xue, Song
Posgai, Amanda
Wasserfall, Clive
Myhr, Courtney
Campbell-Thompson, Martha
Mathews, Clayton E.
Brusko, Todd
Rabinovitch, Alex
Sayinov, Alexei
Battaglia, Manuela
Schatz, Desmond
Haller, Michael
Atkinson, Mark A.
DIABETES, 2015, 64 (11) : 3873 - 3884
[5] CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
Citro, Antonio
Valle, Andrea
Cantarelli, Elisa
Mercalli, Alessia
Pellegrini, Silvia
Liberati, Daniela
Daffonchio, Luisa
Kastsiuchenka, Olga
Ruffini, Pier Adelchi
Battaglia, Manuela
Allegretti, Marcello
Piemonti, Lorenzo
DIABETES, 2015, 64 (04) : 1329 - 1340
[6] Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
Trivedi, Prerak M.
Graham, Kate L.
Scott, Nicholas A.
Jenkins, Misty R.
Majaw, Suktilang
Sutherland, Robyn M.
Fynch, Stacey
Lew, Andrew M.
Burns, Christopher J.
Krishnamurthy, Balasubramanian
Brodnicki, Thomas C.
Mannering, Stuart I.
Kay, Thomas W.
Thomas, Helen E.
DIABETES, 2017, 66 (06) : 1650 - 1660
[7] Prolactin Prevents and Reverses Recent-Onset Type 1 Diabetes in NOD Mice
Kondegowda, Nagesha Guthalu
Fenutria, Rafael
Li, Rosemary
Hampton, Rollie
Vasavada, Rupangi
DIABETES, 2017, 66 : A570 - A570
[8] A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice
Gisela M. Vaitaitis
Michael H. Olmstead
Dan M. Waid
Jessica R. Carter
David H. Wagner
Diabetologia, 2014, 57 : 2366 - 2373
[9] The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
Davoodi-Semiromi, Abdoreza
Wasserfall, Clive H.
Xia, Chang Qing
Cooper-DeHoff, Rhonda M.
Wabitsch, Martin
Clare-Salzler, Michael
Atkinson, Mark
PLOS ONE, 2012, 7 (05):
[10] A CD40-targeted peptide controls and reverses type 1 diabetes in NOD mice
Vaitaitis, Gisela M.
Olmstead, Michael H.
Waid, Dan M.
Carter, Jessica R.
Wagner, David H., Jr.
DIABETOLOGIA, 2014, 57 (11) : 2366 - 2373

← 1 2 3 4 5 →